Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

3.93
Delayed Data
As of Dec 02
 +0.025 / +0.64%
Today’s Change
1.63
Today|||52-Week Range
5.29
+94.31%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close3.90
Today’s open3.90
Day’s range3.80 - 4.00
Volume30,622
Average volume (3 months)100,447
Market cap$59.4M
Dividend yield--
Data as of 3:05pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+72.14%
Earnings growth (next 5 years)--
Revenue growth (last year)+315.65%
P/E ratioNM
Price/Sales1.28
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTECIntec Pharma Ltd+0.05+0.97%
INFIInfinity Pharmaceuti...+0.01+0.84%
JNPJuniper Pharmaceutic...+0.05+0.93%
ADMPAdamis Pharmaceutica...-0.05-1.75%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$4.4M
Annual profit (last year)-$19.0M
Net profit margin-433.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer, Secretary &
Treasurer
Tom Paulson
Corporate headquarters
Emeryville, California

Forecasts


Search for Jobs